|
Home > Articles
Radionuclides in the management of thyroid cancer
Abstract
Nuclear medicine imaging was born over 60 years ago with imaging of thyroid conditions. Most of our present
imaging devices were developed for imaging of the thyroid and thyroid cancer. Millions of patients in over 100
countries have been diagnosed and treated for thyroid cancer using nuclear medicine techniques. It remains, however,
one of the most dynamic areas of development in nuclear medicine with new roles for positron emission tomography
and receptor based imaging. In addition to this is research into combinations of genetic therapy and radioisotopes and
receptor based therapy using beta emitting analogues of somatostatin. Despite the use of ultrasound computed
tomography and magnetic resonance, nuclear medicine techniques remain central to both imaging and therapy
in thyroid disease and the field has recently become one of the most dynamic within the specialty.
Author
J.R. Buscombe
Contact Details
Corresponding address:
Dr John Buscombe, Nuclear Medicine, Royal Free Hospital, Pond Street, London, NW3 2QG, UK
Reference
ICIS Cancer Imaging Volume 7 Issue 1
DOI: 10.1102/1470-7330.2007.0029
Date Posted
17 December 2007
Open Access is provided for this article.
Print PDF
Size
2.79 MB
Minimum Estimated Download Times
ADSL 2Mb/s (Broadband): |
11 seconds |
ADSL 512Kb/s (Broadband): |
44 seconds |
64 Kb/s (ISDN): |
5 minutes 57 seconds |
33.3 Kb/s (Typical Modem): |
11 minutes 27 seconds |
|
